Systemic use of selective iNOS inhibitor 1400W or non-selective NOS inhibitor l-NAME differently affects systemic...

Area of Science:

• Pharmacology
• Immunology
• Microbiology

Background:

• Nitric oxide synthase (NOS) inhibitors are known to mitigate local tissue damage in gingivitis and periodontal disease by reducing nitroxidative stress.
• However, the systemic effects of these inhibitors in the context of periodontal disease remain largely uninvestigated.

Purpose of the Study:

• To investigate the systemic effects of NOS inhibitors in a murine model of chronic oral infection with Porphyromonas gingivalis.
• To determine the impact of selective and non-selective NOS inhibition on nitric oxide (NO) and plasma nitrite/nitrate (NOx) levels.

Main Methods:

• A murine model was established using chronic oral inoculation with live Porphyromonas gingivalis or sterile broth.
• Mice were treated with either a non-selective NOS inhibitor (l-NAME) or a selective iNOS inhibitor (1400W).
• Organ NO and plasma NOx levels were measured and compared between treatment groups and controls.

Main Results:

• Porphyromonas gingivalis inoculation led to generalized NO production in organs and NOx in plasma.
• Treatment with the selective iNOS inhibitor 1400W significantly reduced NO and NOx levels in infected mice.
• The non-selective NOS inhibitor l-NAME was largely ineffective and, in some cases, promoted NO/NOx formation, with both inhibitors enhancing NO/NOx in sham-inoculated animals.

Conclusions:

• Systemic administration of 1400W and l-NAME differentially modulates systemic nitric oxide formation in the context of Porphyromonas gingivalis-induced oral challenge.
• Further research is warranted to fully elucidate the sequelae and therapeutic potential of these interventions.